Sun Pharmaceutical Industries Limited vs Torrent Pharmaceuticals Limited

A side-by-side comparison of Sun Pharmaceutical Industries Limited (SUNPHARMA) and Torrent Pharmaceuticals Limited (TORNTPHARM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Sun Pharmaceutical Industries Limited leads SUNPHARMA vs TORNTPHARM on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation31
  • Profitability22
  • Growth02
  • Size & financial health40
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

SUNPHARMA takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

36.79
P/E ratio
71.32
5.35
P/B ratio
22.29
0.86%
Dividend yield
0.77%
₹47.80
EPS
₹63.92

Profitability

Even

How efficiently each company turns capital and sales into profit. Higher is better.

13.74%
Return on equity
25.78%
17.46%
Return on capital
13.91%
30.33%
EBITDA margin
32.61%
19.69%
Net margin
15.29%

Growth

TORNTPHARM takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.03%
Revenue CAGR (3Y)
13.27%
10.57%
Profit CAGR (3Y)
19.75%

Size & financial health

SUNPHARMA takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹4.22L Cr
Market cap
₹1.73L Cr
₹58,462 Cr
Revenue
₹13,980 Cr
₹11,509 Cr
Net profit
₹2,138 Cr
0.06
Debt / equity
1.79
Sun Pharmaceutical Industries Limited
  • + ["Company has delivered good profit growth of 38.3% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 33.4%", "Company is almost debt free."]
  • − ["Stock is trading at 5.05 times its book value"]
Torrent Pharmaceuticals Limited
  • + ["Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 67.6%"]
  • − ["Stock is trading at 20.67 times its book value", "Company has a high debt to equity ratio of 1.79."]
Sun Pharmaceutical Industries Limited full analysis Torrent Pharmaceuticals Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.